Beneyto, Aleix; Bertachi, Arthur; Bondía Company, Jorge; Vehí, Josep(Institute of Electrical and Electronics Engineers, 2020-03)
[EN] The artificial pancreas (AP) system or closed-loop blood glucose (BG) regulation is a technological advancement that aims to relieve diabetic subjects from their current decision-making burden while tightening their ...
[EN] Continuous glucose monitoring (CGM) plays an important role in treatment decisions for patients with type 1 diabetes under conventional or closed-loop therapy. Physical activity represents a great challenge for diabetes ...
Barceló-Rico, Fátima; Diez, José-Luís; Rossetti, Paolo; Vehi, Josep; Bondía Company, Jorge(Institute of Electrical and Electronics Engineers, 2013)
[EN] Minimally or noninvasive continuous glucose monitors estimate plasma glucose from compartments alternative to blood, and may revolutionize the management of diabetes. However, the accuracy of current devices is still ...
[EN] Background: People with insulin-dependent diabetes rely on an intensified insulin regimen. Despite several guidelines, they
are usually impractical and fall short in achieving optimal glycemic outcomes. In this work, ...
Revert, Ana; Calm, Remei; Vehí, Josep; Bondía Company, Jorge(Institute of Electrical and Electronics Engineers, 2011-02)
[EN] Intensive insulin therapy in type 1 diabetes is based on the well-established practice of adjusting basal and bolus insulin independently. Basal insulin delivery is designed to optimize glucose concentrations between ...
[EN] In this paper, the problem of tackling uncertainty in the prediction of postprandial blood glucose is analyzed. Two simulation approaches, Monte Carlo and interval models, are studied and compared. Interval simulation ...
[EN] Many problems are confronted when characterizing a type 1 diabetic patient such as model mismatches, noisy inputs, measurement errors and huge variability in the glucose profiles. In this work we introduce a new ...
[EN] Background:
Closed-loop (CL) systems aims to outperform usual treatments in blood glucose control and continuous glucose monitors (CGM) are a key component in such systems. Meals represents one of the main disturbances ...
[EN] The aim of this study was to apply a methodology based on compositional data analysis (CoDA) to categorise glucose profiles obtained from continuous glucose monitoring systems. The methodology proposed considers ...
Considering the difficulty in selecting correct insulin doses and the problem of hyper- and hypoglycemia episodes in type 1 diabetes, dosage-aid systems are very useful for these patients. A model-based approach to this ...
Insulin therapy in type 1 diabetes aims to mimic the pattern of endogenous insulin secretion found in healthy subjects. Glucose-insulin models are widely used in the development of new predictive control strategies in order ...
The behavior of three insulin action and glucose kinetics models was assessed for an insulin therapy regime in the presence of patient variability. For this purpose, postprandial glucose in patients with type 1 diabetes ...
Continuous glucose monitors can measure interstitial glucose concentration in real time for closed-loop glucose control systems, known as artificial pancreas. These control systems use an insulin feedback to maintain plasma ...
[EN] The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 diabetes using a continuous glucose monitor informed controller that adjusts insulin infusion via an insulin pump. ...